APA (7th ed.) Citation

P, U., N, P., J, O., R, S., P, S., B, S., . . . P, I. (2025). Humoral SARS-CoV-2 immunogenicity wanes 3 months after heterologous inactivated vaccine followed by ChAdOx1 nCoV-19 in autoimmune rheumatic diseases. Asian Pacific journal of allergy and immunology, 43(3), 648. https://doi.org/10.12932/AP-280722-1420

Chicago Style (17th ed.) Citation

P, Uea-Areewongsa, Pinpathomrat N, Ongarj J, Sophonmanee R, Seepathomnarong P, Seeyankem B, Surasombatpattana S, and Intapiboon P. "Humoral SARS-CoV-2 Immunogenicity Wanes 3 Months After Heterologous Inactivated Vaccine Followed by ChAdOx1 NCoV-19 in Autoimmune Rheumatic Diseases." Asian Pacific Journal of Allergy and Immunology 43, no. 3 (2025): 648. https://doi.org/10.12932/AP-280722-1420.

MLA (9th ed.) Citation

P, Uea-Areewongsa, et al. "Humoral SARS-CoV-2 Immunogenicity Wanes 3 Months After Heterologous Inactivated Vaccine Followed by ChAdOx1 NCoV-19 in Autoimmune Rheumatic Diseases." Asian Pacific Journal of Allergy and Immunology, vol. 43, no. 3, 2025, p. 648, https://doi.org/10.12932/AP-280722-1420.